378777222	378777222	CD	B-NP	O
|	|	NNP	I-NP	O
BC	BC	NNP	I-NP	B-cell_type
|	|	VBD	B-VP	O
24492761	24492761	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5750684	5750684	CD	B-NP	O
|	|	CC	I-NP	O
8/29/2005	8/29/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/23/2005	1/23/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
BURT	BURT	NNP	B-NP	O
EVERETT	EVERETT	NNP	I-NP	O
PENISSON	PENISSON	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DATE	DATE	NNP	I-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
be	be	VB	I-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O

SERVICE	SERVICE	NN	B-NP	O
:	:	:	O	O
GMS	GMS	NNP	B-NP	O
Ra	Ra	NNP	I-NP	O
PRIMARY	PRIMARY	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Failure	Failure	NN	B-NP	O
to	to	TO	B-VP	O
thrive	thrive	VB	I-VP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
gastroesophageal	gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
venous	venous	JJ	B-NP	O
stasis	stasis	NN	I-NP	O
,	,	,	O	O
postherpetic	postherpetic	JJ	B-NP	O
neuralgia	neuralgia	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
87-year-old	87-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
failure	failure	NN	B-NP	O
to	to	TO	B-VP	O
thrive	thrive	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Tapo	Tapo	NNP	B-NP	O
Waycent	Waycent	NNP	I-NP	O
Smouthnew	Smouthnew	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
in	in	IN	B-PP	O
early	early	JJ	B-NP	O
October	October	NNP	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ultimately	ultimately	RB	B-ADVP	O
with	with	IN	B-PP	O
ethacrynic	ethacrynic	JJ	B-NP	O
acid	acid	NN	I-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	O
on	on	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
and	and	CC	O	O
itching	itch	VBG	B-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
seven-day	seven-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
returned	return	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
vomiting	vomit	VBG	I-VP	O
and	and	CC	O	O
appears	appear	VBZ	B-VP	O
severely	severely	RB	I-VP	O
dehydrated	dehydrate	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reported	report	VBD	B-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	O	O
vomiting	vomit	VBG	B-VP	O
for	for	IN	B-PP	O
eight	eight	CD	B-NP	O
to	to	TO	I-NP	O
nine	nine	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
intermittent	intermittent	JJ	B-NP	O
nonbloody	nonbloody	JJ	I-NP	O
,	,	,	I-NP	O
nonbilious	nonbilious	JJ	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reported	report	VBD	B-VP	O
dysphagia	dysphagia	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
two	two	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
describes	describe	VBZ	B-VP	O
recent	recent	JJ	B-NP	O
dysuria	dysuria	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
bowel	bowel	NN	I-NP	O
movement	movement	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
flatus	flatus	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
complains	complain	VBZ	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	B-protein
right	right	JJ	I-NP	I-protein
ear	ear	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
due	due	IN	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
postherpetic	postherpetic	JJ	I-NP	O
neuralgia	neuralgia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
significantly	significantly	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
p.o.	p.o.	NN	B-NP	O
intake	intake	NN	I-NP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-VP	O
generalized	generalize	VBN	B-NP	O
weakness	weakness	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
gastroesophageal	gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
venous	venous	JJ	B-NP	O
stasis	stasis	NN	I-NP	O
,	,	,	O	O
T6	T6	NN	B-NP	O
fracture	fracture	NN	I-NP	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
back	back	RB	I-NP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
herpes	herpes	NN	B-NP	O
zoster	zoster	NN	I-NP	O
with	with	IN	B-PP	O
postherpetic	postherpetic	JJ	B-NP	O
neuralgia	neuralgia	NN	I-NP	O
affecting	affect	VBG	B-VP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
face	face	NN	I-NP	O
and	and	CC	I-NP	O
ear	ear	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
pace	pace	NN	I-NP	O
replacement	replacement	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
guaiac-positive	guaiac-positive	JJ	B-NP	O
stools	stool	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Colace	Colace	NN	B-NP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
OxyContin	OxyContin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
calcium	calcium	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Neurontin	Neurontin	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Fosamax	Fosamax	NN	B-NP	B-protein
70	70	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
week	week	NN	I-NP	I-protein
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ethacrynic	ethacrynic	JJ	B-NP	O
acid	acid	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
Lasix	Lasix	NN	B-NP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	B-protein
,	,	,	O	O
erythromycin	erythromycin	NN	B-NP	O
,	,	,	O	O
capsicum	capsicum	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
quinidine	quinidine	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Recently	Recently	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Orva	Orva	NNP	I-NP	O
Sonapa	Sonapa	NNP	I-NP	O
Alblands	Alblands	NNP	I-NP	O
in	in	IN	B-PP	O
ME	ME	NNP	B-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADVP	O
,	,	,	O	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
in	in	IN	B-PP	O
Rham	Rham	NNP	B-NP	O
En	En	NNP	I-NP	O
Ma	Ma	NNP	I-NP	O
At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
is	be	VBZ	B-VP	O
ambulatory	ambulatory	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
.	.	.	O	O

Remote	Remote	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
,	,	,	O	O
quit	quit	VBD	B-VP	O
50	50	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Asthma	Asthma	NN	B-NP	O
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
brothers	brother	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
96	96	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
81	81	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
119/56	119/56	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
uncomfortable	uncomfortable	JJ	B-NP	O
and	and	CC	O	O
ill	ill	VB	B-VP	O
appearing	appear	VBG	I-VP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
equal	equal	JJ	B-ADJP	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Mucous	Mucous	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
are	be	VBP	B-VP	O
dry	dry	JJ	B-ADJP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
is	be	VBZ	B-VP	O
otherwise	otherwise	RB	B-ADJP	O
clear	clear	JJ	I-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
ptosis	ptosis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lid	lid	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
exquisite	exquisite	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
base	base	NN	I-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
ear	ear	NN	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
7	7	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
otherwise	otherwise	RB	B-ADJP	O
supple	supple	JJ	I-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
tenderness	tenderness	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
active	active	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Foley	Foley	NN	B-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
draining	drain	VBG	B-VP	O
a	a	DT	B-NP	O
dark	dark	JJ	I-NP	O
,	,	,	I-NP	O
cloudy	cloudy	JJ	I-NP	O
urine	urine	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Violaceous	Violaceous	JJ	B-NP	O
skin	skin	NN	I-NP	O
changes	change	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
legs	leg	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

2	2	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
erythema	erythema	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
medial	medial	JJ	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
infected	infected	JJ	B-NP	O
ulceration	ulceration	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
Alert	Alert	NNP	B-NP	O
and	and	CC	O	O
oriented	orient	VBN	B-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
intact	intact	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
except	except	IN	B-PP	O
right	right	JJ	B-NP	B-protein
lid	lid	JJ	I-NP	I-protein
ptosis	ptosis	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
feel	feel	VB	I-VP	O
well	well	RB	B-ADJP	O
enough	enough	RB	I-ADJP	O
to	to	TO	B-VP	O
cooperate	cooperate	VB	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
neurologic	neurologic	JJ	I-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
her	her	PRP$	B-NP	O
strength	strength	NN	I-NP	O
was	be	VBD	B-VP	O
symmetric	symmetric	JJ	B-ADJP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Remarkable	Remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
chemistry	chemistry	NN	I-NP	O
panel	panel	NN	I-NP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

BUN	BUN	NN	B-NP	B-protein
was	be	VBD	B-VP	O
22	22	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.1	1.1	CD	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
13.27	13.27	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
41.4	41.4	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
448	448	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	B-DNA
25	25	CD	I-NP	I-DNA
,	,	,	O	O
AST	AST	NN	B-NP	O
35	35	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
339	339	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
1.0	1.0	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	B-protein
4.0	4.0	CD	I-NP	I-protein
,	,	,	O	O
amylase	amylase	NN	B-NP	B-protein
39	39	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
lipase	lipase	NN	B-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
An	An	DT	B-NP	O
87-year-old	87-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
dehydration	dehydration	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
mainly	mainly	RB	B-ADVP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
chronic	chronic	JJ	B-NP	O
Foley	Foley	NNP	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
a.	a.	NNP	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
aspirin	aspirin	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
guaiac-positive	guaiac-positive	JJ	B-NP	O
stool	stool	NN	I-NP	O
.	.	.	O	O

b.	b.	RB	B-ADVP	O
Pump	Pump	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
dry	dry	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
p.o.	p.o.	FW	B-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
last	last	JJ	I-NP	O
echo	echo	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
presumed	presumed	JJ	I-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
mild-to-moderate	mild-to-moderate	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
of	of	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
artery	artery	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
64	64	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
plus	plus	CC	O	O
right	right	JJ	B-NP	B-protein
atrial	atrial	JJ	I-NP	I-protein
pressure	pressure	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
ethacrynic	ethacrynic	JJ	I-NP	O
acid	acid	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
given	give	VBN	B-PP	O
dehydration	dehydration	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
towards	towards	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
titrated	titrate	VBD	B-VP	O
out	out	RP	B-PRT	O
to	to	TO	B-VP	O
b.i.d.	b.i.d.	VB	I-VP	O
dosing	dosing	NN	B-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
a	a	DT	B-NP	O
slightly	slightly	RB	I-NP	O
negative	negative	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
balance	balance	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
and	and	CC	I-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
after	after	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
adequately	adequately	RB	I-VP	O
hydrated	hydrate	VBN	I-VP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

c.	c.	NN	B-NP	O
Rhythm	Rhythm	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
pacer	pacer	NN	I-NP	O
placed	place	VBN	B-VP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
V-paced	V-paced	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
at	at	IN	B-PP	O
goal	goal	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
admission	admission	NN	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
read	read	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
streaky	streaky	JJ	I-NP	O
opacity	opacity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lung	lung	NN	I-NP	O
base	base	NN	I-NP	O
possibly	possibly	RB	B-VP	O
representing	represent	VBG	I-VP	O
an	an	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
curve	curve	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
artifact	artifact	NN	B-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
lung	lung	NN	I-NP	O
volume	volume	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-VP	O
no	no	DT	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
lung	lung	NN	B-NP	B-protein
exam	exam	NN	I-NP	I-protein
clear	clear	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomit	VBG	B-VP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
p.o.	p.o.	NN	I-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reported	report	VBD	B-VP	O
no	no	DT	B-NP	O
bowel	bowel	NN	I-NP	O
movement	movement	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
weeks	week	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
KUB	KUB	NN	I-NP	B-protein
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
obstruction	obstruction	NN	B-NP	O
or	or	CC	O	O
free	free	JJ	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
stool	stool	NN	B-NP	O
softeners	softener	NNS	I-NP	O
and	and	CC	I-NP	O
laxatives	laxative	NNS	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
and	and	CC	O	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
regular	regular	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
gastroesophageal	gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	O	O
vomiting	vomit	VBG	B-VP	O
improved	improve	VBN	I-VP	O
overall	overall	RB	B-ADVP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
intermittently	intermittently	RB	B-ADVP	O
returned	return	VBD	B-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
cause	cause	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
contribution	contribution	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
opioid	opioid	JJ	I-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
early	early	RB	B-ADVP	O
on	on	IN	B-PP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
to	to	TO	B-VP	O
address	address	VB	I-VP	O
her	her	PRP$	B-NP	O
postherpetic	postherpetic	JJ	I-NP	O
neuralgia	neuralgia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
nausea	nausea	NN	I-NP	O
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
Reglan	Reglan	NN	B-NP	O
.	.	.	O	O

Nausea	Nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
was	be	VBD	B-VP	O
improved	improve	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
better	good	JJR	I-NP	O
p.o.	p.o.	NN	I-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
dysphagia	dysphagia	NN	B-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
months	month	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
occurred	occur	VBD	B-VP	O
mainly	mainly	RB	B-ADVP	O
with	with	IN	B-PP	O
solid	solid	JJ	B-NP	O
foods	food	NNS	I-NP	O
.	.	.	O	O

Per	Per	NNP	B-NP	O
Speech	Speech	NNP	I-NP	O
and	and	CC	O	O
Swallow	Swallow	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
soft	soft	JJ	I-NP	O
mechanical/thin	mechanical/thin	NN	I-NP	O
liquid	liquid	NN	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
concerned	concern	VBN	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
obstructive	obstructive	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
video	video	NN	I-NP	O
swallow	swallow	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
on	on	IN	B-PP	O
3/4/05	3/4/05	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
aspiration	aspiration	NN	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
passage	passage	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
of	of	IN	B-PP	O
varying	vary	VBG	B-NP	O
consistencies	consistency	NNS	I-NP	O
-LRB-	-LRB-	JJ	B-ADJP	O
although	although	IN	B-SBAR	O
a	a	DT	B-NP	O
note	note	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
of	of	IN	B-PP	O
cricopharyngeal	cricopharyngeal	JJ	B-NP	B-protein
prominence	prominence	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Speech	Speech	NNP	B-NP	O
and	and	CC	I-NP	O
Swallow	Swallow	NNP	I-NP	O
recommended	recommend	VBD	B-VP	O
a	a	DT	B-NP	O
minced	minced	JJ	I-NP	O
solid/thin	solid/thin	JJ	I-NP	O
liquid	liquid	NN	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
tolerated	tolerate	VBN	I-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
alkaline	alkaline	NN	I-NP	O
phosphatase	phosphatase	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
with	with	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
GGT	GGT	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
of	of	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
last	last	JJ	I-NP	O
admission	admission	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2005	2005	CD	I-NP	O
showed	show	VBD	B-VP	O
gallstones	gallstone	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
process	process	NN	I-NP	O
to	to	TO	B-VP	O
explain	explain	VB	I-VP	O
the	the	DT	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
in	in	IN	B-PP	O
alkaline	alkaline	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
right	right	JJ	I-NP	B-protein
upper	upper	JJ	I-NP	I-protein
quadrant	quadrant	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Renal/FEN	Renal/FEN	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
given	give	VBN	I-VP	O
intravenous	intravenous	JJ	B-NP	O
fluids	fluid	NNS	I-NP	O
for	for	IN	B-PP	O
dehydration	dehydration	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
empirically	empirically	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
returned	return	VBD	B-VP	O
was	be	VBD	B-VP	O
Staph	Staph	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
indwelling	indwell	VBG	I-VP	O
Foley	Foley	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	I-VP	O
doxycycline	doxycycline	VB	I-VP	O
-LRB-	-LRB-	RP	B-PRT	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
allergic	allergic	JJ	B-ADJP	O
to	to	TO	B-PP	O
sulfa	sulfa	NN	B-NP	O
drugs	drug	NNS	I-NP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
erythromycin	erythromycin	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
afebrile	afebrile	RB	B-ADVP	O
through	through	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
retention	retention	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
occasions	occasion	NNS	I-NP	O
where	where	WRB	B-ADVP	O
an	an	DT	B-NP	O
attempt	attempt	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
remove	remove	VB	I-VP	O
her	her	PRP	B-NP	O
Foley	Foley	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
opioid	opioid	JJ	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
Foley	Foley	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Urology	Urology	NNP	B-NP	O
on	on	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
postherpetic	postherpetic	JJ	B-NP	O
neuralgia	neuralgia	NN	I-NP	O
affecting	affect	VBG	B-VP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
face/ear	face/ear	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
OxyContin	OxyContin	NN	B-NP	O
and	and	CC	I-NP	O
oxycodone	oxycodone	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
out	out	RP	B-PRT	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
attempt	attempt	NN	I-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
her	her	PRP	B-NP	O
more	more	RBR	B-ADJP	O
comfortable	comfortable	JJ	I-ADJP	O
and	and	CC	O	O
Neurontin	Neurontin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
titrated	titrate	VBN	I-VP	O
out	out	RP	B-PRT	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
her	her	PRP$	B-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	I-NP	O
urinary	urinary	JJ	I-NP	O
retention	retention	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
opioid	opioid	JJ	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
trial	trial	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
lidoderm	lidoderm	NN	I-NP	O
patch	patch	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
affected	affect	VBN	I-NP	O
area	area	NN	I-NP	O
was	be	VBD	B-VP	O
attempted	attempt	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
goal	goal	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
2	2	CD	I-NP	O
to	to	TO	I-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Code	Code	NN	B-NP	O
status	status	NN	I-NP	O
:	:	:	O	O
DNR/DNI	DNR/DNI	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Disposition	Disposition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Eddie	Eddie	NNP	I-NP	O
Nitterhouse	Nitterhouse	NNP	I-NP	O
In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
made	make	VBN	I-VP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Nang	Nang	NNP	I-NP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
a.m.	a.m.	RB	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
made	make	VBN	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Storch	Storch	NNP	I-NP	O
in	in	IN	B-PP	O
Neurology	Neurology	NNP	B-NP	O
on	on	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
a.m.	a.m.	RB	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
requested	request	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
basic	basic	JJ	I-NP	O
metabolic	metabolic	JJ	I-NP	O
panel	panel	NN	I-NP	O
be	be	VB	B-VP	O
monitored	monitor	VBN	I-VP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
ethacrynic	ethacrynic	JJ	B-NP	O
acid	acid	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
for	for	IN	B-PP	O
fluid	fluid	NN	B-NP	O
accumulation	accumulation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
deconditioned	deconditione	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
discharge	discharge	NN	I-NP	O
medications	medication	NNS	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
dictated	dictate	VBN	I-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
addendum	addendum	NN	I-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
discharge	discharge	NN	I-NP	O
summary	summary	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
5-4891603	5-4891603	CD	B-NP	O
ISSten	ISSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Jerry	Jerry	NNP	B-NP	O
Stammler	Stammler	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
IJELOS	IJELOS	NNP	I-NP	O
MEMORIAL	MEMORIAL	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
Ter	Ter	NNP	I-NP	O
San	San	NNP	I-NP	O
Longgao	Longgao	NNP	I-NP	O
Balt	Balt	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Levi	Levi	NNP	B-NP	O
Jackie	Jackie	NNP	I-NP	O
Corderman	Corderman	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
HOVDA	HOVDA	NN	B-NP	B-protein
,	,	,	O	O
GARTH	GARTH	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
QUIMET	QUIMET	NNP	B-NP	O
,	,	,	O	O
HAROLD	HAROLD	NNP	B-NP	O
DAN	DAN	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
3046159	3046159	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/9/05	10/9/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/27/05	1/27/05	CD	B-NP	O

